iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
15 hedge funds and large institutions have $18M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
101% more capital invested
Capital invested by funds: $8.94M → $18M (+$9.02M)
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
21.52% more ownership
Funds ownership: 25.13% → 46.65% (+22%)
6% less funds holding
Funds holding: 16 → 15 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$7.86M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$265K |
| 3 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$45.3K |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$41.9K |
| 5 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$10K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SWM
Strategic Wealth Management
Kirkland,
Washington
|
-$132K |
| 2 |
Morgan Stanley
New York
|
-$106K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$46K |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
-$20.7K |
| 5 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
-$16K |
IEIH Hedge Fund Activity: Q2 2021 in Review
15 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q2 2021, worth a combined $18M — up 101% from $8.94M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IEIH and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 5 added.
The largest buyer was Cetera Advisor Networks, opening a new position worth an estimated $7.86M. The largest seller was Strategic Wealth Management, cutting an estimated $132K.
- 15 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q2 2021, down from 16 in Q1 2021.
- Funds reported $18M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q2 2021, up 101% quarter-over-quarter.
- 3 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q2 2021 and 4 closed out, a net change of -1 holder.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q2 2021 was Cetera Advisor Networks, an estimated $7.86M added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q2 2021 was Strategic Wealth Management, an estimated $132K sold.
Based on aggregated 13F filings for Q2 2021.